Impact of the FDS Approval of Adalimumab on the Management of Uveitis

Authors

Andrea McCullum Mejia
Adam Grunbaum
Daniel Rodney
Grace Levy-Clarke

Author Institutions

HCA Healthcare

Publication Date

01-01-2021

Document Type

Image

Fulltext URL

https://scholarlycommons.hcahealthcare.com/context/westflorida2021/article/1042/viewcontent

URL

http://scholarlycommons.hcahealthcare.com/westflorida2021/40

Division

West Florida

Hospital

Regional Medical Center Bayonet Point

Publisher

HCA Healthcare Graduate Medical Education

Relationshiptofacility

Resident

Specialty

Rheumatology

Discipline

Analytical, Diagnostic and Therapeutic Techniques and Equipment
Diseases
Eye Diseases
Medical Specialties
Medicine and Health Sciences
Ophthalmology
Rheumatology
Therapeutics

Download Link

https://scholarlycommons.hcahealthcare.com/context/westflorida2021/article/1042/type/native/viewcontent

Institution

HCA
HCA Healthcare
Regional Medical Center Bayonet Point
Bayonet Point Regional Medical Center

HCA Healthcare Graduate Medical Education 2021 Research Days

Impact of the FDS Approval of Adalimumab on the Management of Uveitis